United States · FDA National Drug Code directory
tafluprost
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 42571-264_4c55f162-175b-d458-e063-6394a90a066f
- Product NDC
- 42571-264
- Form
- SOLUTION/ DROPS
- Composition / generic term
- tafluprost opthalmic
- Labeler
- Micro Labs Limited
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20221118
- Source listing expiry
- 20271231
Source-listed ingredients
- TAFLUPROST — .0045 mg/.3mL
These values do not establish equivalence or a dose recommendation.
Packages
- 1 POUCH in 1 CARTON (42571-264-26) / 15 VIAL in 1 POUCH / .3 mL in 1 VIAL · 42571-264-26
- 2 POUCH in 1 CARTON (42571-264-73) / 15 VIAL in 1 POUCH / .3 mL in 1 VIAL · 42571-264-73
- 6 POUCH in 1 CARTON (42571-264-74) / 15 VIAL in 1 POUCH / .3 mL in 1 VIAL · 42571-264-74
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →